What if sleep could help prevent Alzheimer’s disease? A new landmark study by researchers at Applied Cognition, a clinical-stage therapeutic company, points to the brain’s glymphatic system, its fluid-based “clean-up” pathway, as a key driver of overnight clearance of Alzheimer’s-linked proteins. The researchers found that during normal sleep, levels of amyloid beta and […]
ARTICLES
Americans are ‘Doomscrolling’ at Bedtime, Prioritizing Screen Time Over Sleep
Many Americans wind down their day with a scroll through the latest headlines, and that nightly habit may be taking a toll on their rest. According to a new survey from the American Academy of Sleep Medicine, over one-third (38%) of adults say using their phone or tablet before bed to view […]
Techno Xperts Builds Sleep Diagnostics Distribution Platform for Latin America
After more than two decades in the global sleep medicine industry, Julia Sarmiento, former Director of Sales of the Americas for SOMNOmedics US, has launched and rapidly expanded Techno Xperts, a dedicated distribution platform serving Latin America. The company was established to increase access to advanced sleep diagnostics technologies while […]
Jamison Spencer, DDS, MS, Joins Sleep Education Partners
Jamison Spencer, DDS, MS, will serve as a contributing author for Sleepedu. His responsibilities will be primarily to author dental-sleep-related courses. Dr. Spencer has a passion for bringing practicing sleep dentists and physicians together to foster understanding and mutual respect between the two groups. His courses will discuss those relationships […]
Clear Chronic Care Expands Nationally, Enters Sleep Medicine Market
Clear Chronic Care announced continued national expansion of its Medicare-focused Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) platform, reinforcing its position as a long-term infrastructure partner to physician practices navigating value-based reimbursement. The company also announced strategic expansion into sleep medicine, where chronic oversight and adherence management are […]
ProSomnus Secures $38 Million Investment from Catalio Capital to Scale Smart Sleep Medicine
ProSomnus Sleep Technologies announced a strategic investment from Catalio Capital Management, L.P. to accelerate the global expansion of its technology-enabled sleep health platform. Under the agreement, Catalio, a premier healthcare-focused investment firm, has committed up to $38 million to advance development of next-generation remote patient monitoring (RPM) and proprietary sleep […]
Harmony Biosciences Receives FDA Approval for WAKIX for the Treatment of Cataplexy in Pediatric Narcolepsy
Harmony Biosciences announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug application (sNDA) for WAKIX® (pitolisant) tablets for the treatment of cataplexy in pediatric patients 6 years of age and older with narcolepsy. WAKIX is now the first-and-only FDA-approved non-scheduled treatment for pediatric and adult […]
Resmed Introduces Full Face Fabric Mask Designed for Comfort and Improved Sleep Health
Resmed, announced the launch of the AirTouch™ F30i Comfort mask in the United States, a new CPAP (continuous positive airway pressure) full face mask. With a soft, breathable1 fabric, the AirTouch F30i Comfort is designed to help more people start and stay on CPAP therapy. The AirTouch F30i Comfort reflects Resmed’s dedication […]
In November, the Percentage of Patients with a Telehealth Claim Increased Nationally and Regionally
The percentage of patients with a telehealth claim increased nationally and in every region in November 2025, according to FAIR Health’s Monthly Telehealth Regional Tracker. Nationally, that percentage increased from 14.5 percent in October to 15.0 percent in November, a 3.6 percent rise. The largest increase was in the Midwest, at 5.1 […]
Alkermes Completes Acquisition of Avadel, Accelerating Entry Into Sleep Medicine Market
Alkermes plc and Avadel Pharmaceuticals plc, announced Alkermes’ completion of its acquisition of Avadel, a commercial-stage biopharmaceutical company. The acquisition adds Avadel’s FDA-approved product, LUMRYZ®, to Alkermes’ commercial portfolio, and provides Alkermes with a commercial organization experienced in this disease state. This strategic move accelerates Alkermes’ entry into the sleep […]













